MTRN (MTRN)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 5/9, Altman Z 4.3.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of the company reveal a significant capital allocation challenge, as the return on invested capital sits at 5.7%, substantially below the estimated weighted average cost of capital of 9.4%. This negative spread of -3.7% indicates that current operations are destroying value rather than generating it above the hurdle rate required by equity and debt holders. While the Piotroski F-Score of 5/9 suggests moderate financial strength with no immediate distress signals, the Altman Z-Score of 4.3 places the entity in a relatively safe zone away from bankruptcy territory, yet far from the robust scores seen in high-quality growth firms. The DuPont decomposition is skewed by thin net margins of just 4.2% despite gross margins holding at 17.3%, implying that operating leverage or cost control issues are suppressing overall profitability efficiency rather than low asset turnover driving returns.
Valuation metrics present a stark divergence between current market pricing and intrinsic value models, with the stock trading at a premium P/E multiple of 39.2x. This valuation implies significant future growth expectations embedded in the share price that appear disconnected from recent revenue expansion of only 6% year-over-year. A discounted cash flow analysis suggests a fair value of $18, indicating that the current market price likely exceeds this calculated intrinsic worth by a considerable margin unless anticipated earnings acceleration materializes rapidly to justify the wide valuation gap relative to historical norms and sector peers.
The Beneish M-Score of -2.34 offers some reassurance regarding earnings manipulation risks, suggesting financial statements are unlikely to be aggressively inflated. However, the combination of negative ROIC-WACC spread and a P/E multiple nearly four times the DCF-derived fair value implies that the market is pricing in aggressive future performance improvements that have not yet been realized in fundamentals. Investors must weigh whether the current valuation adequately compensates for the capital destruction occurring at today's operational levels against potential turnaround scenarios suggested by the moderate Piotroski score.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
Sensitivity Matrix
| TG ↓ / WACC → | 7.4% | 9.4% | 11.4% |
|---|---|---|---|
| 2% | $27 | $15 | $8 |
| 3% | $35 | $18 | $10 |
| 4% | $49 | $24 | $13 |
Center = base case. Green = >10% upside, Red = >10% downside vs $274.98.
Pre-computed DCF: WACC=9.4%, terminal growth 3%. Fair value $18 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XME or SLYG, the fund manager is mechanically forced to buy or sell MTRN shares regardless of MTRN's individual fundamentals. We estimate $314M of passive capital is structurally linked to MTRN through 8 tracked ETFs. Passive flows have a limited but growing influence on MTRN's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in MTRN to visualize passive redemption contagion across ETFs and collateral stocks.
If MTRN (MTRN) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Linde plc (LIN) as the most exposed collateral stock, sharing 1 ETFs with MTRN. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 10 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
MTRN Ownership Dynamics
Passive funds hold 1 in every 7 MTRN shares, reducing daily market volatility.
MTRN (MTRN) exerts measurable gravity on the passive index market, currently representing 2.9% of the XME (XME) and 0.3% of the SLYG (SLYG). Across 10 tracked ETFs, approximately 1M shares (13.5% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest MTRN Exposure
Float lock-up computed from 10 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
MTRN Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for MTRN over the past year sits near $120.92 (12% of 252-day volume). The current price of $274.98 trades 127.4% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (12% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
MTRN Capital Efficiency
How efficiently does MTRN convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
MTRN converts 13% of its EBITDA into free cash flow, a low conversion rate suggesting heavy reinvestment. This may indicate a growth phase (building capacity) or structural capital intensity. The 87% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-3.7%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-13 | 962 | $203.65 | $195,911.3 |
| 2026-04-30 | 105 | $172.54 | $18,116.7 |
| 2026-04-21 | 1 | $180.95 | $180.95 |
| 2026-03-26 | 41 | $148.11 | $6,072.51 |
| 2026-03-23 | 2 | $132.06 | $264.12 |
| 2026-03-10 | 162 | $145.23 | $23,527.26 |
| 2026-03-03 | 212 | $166.59 | $35,317.08 |
| 2026-03-02 | 620 | $163.06 | $101,097.2 |
| 2026-02-23 | 225 | $149.03 | $33,531.75 |
| 2026-02-04 | 126 | $145.01 | $18,271.26 |
| 2026-01-20 | 107 | $145.91 | $15,612.37 |
| 2026-01-16 | 34 | $149.19 | $5,072.46 |
| 2025-12-22 | 28 | $126.66 | $3,546.48 |
| 2025-12-17 | 201 | $125.79 | $25,283.79 |
| 2025-12-16 | 458 | $125.99 | $57,703.42 |
| 2025-12-15 | 1,873 | $127.83 | $239,425.59 |
| 2025-11-28 | 71 | $120.79 | $8,576.09 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare MTRN to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-18.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.